BioCryst Pharmaceuticals Inc at Needham Healthcare Conference (Virtual) Transcript
Good morning. Welcome to Needham's 21st Annual Healthcare Conference. I'm Serge Belanger, one of the healthcare analysts at Needham. We're happy to have the -- a big contingent of the BioCryst team with us this morning to give a presentation on BioCryst.
So to start off, I'll hand it over to Jon Stonehouse, who can introduce the team and give us an overview of the company as well as some of the recent developments. So Jon?
Thanks, Serge, and thanks for inviting us to your healthcare conference. With me today is Charlie Gayer, our Chief Commercial Officer; Anthony Doyle, who's here in the office with me, our Chief Financial Officer; Nick Wilder, who is on John Bluth's team in Investor Relations; and John Bluth with Investor Relations.
We're all going to be making some forward-looking statements and those statements have risks, and the risk factors can be found on our
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
